Genetic studies indicate that chromosome 7q is likely to contain an autism susceptibility locus (AUTS1). We have followed a positional candidate gene approach to identify relevant gene(s) and report here the analysis of reelin (RELN), a gene located under our peak of linkage. Screening RELN for DNA changes identified novel missense variants absent in a large control group; however, the low frequency of these mutations does not explain the relatively strong linkage results on 7q. Furthermore, analysis of a previously reported triplet repeat polymorphism and intragenic single nucleotide polymorphisms, using the transmission disequilibrium test, provided no evidence for association with autism in IMGSAC and German singleton families. The analysis of RELN suggests that it probably does not play a major role in autism aetiology, although further analysis of several missense mutations is warranted in additional affected individuals.
Introduction
Autism (MIM209850) is a neurodevelopmental disorder characterised by impairments in communication and social interactions, with restricted and stereotyped patterns of behaviours and interests. The population prevalence of autism is 12-17 in 10 000, 1 with a male to female ratio of 4 : 1 2 and onset in the first 3 years of life. Twin and family studies point to a strong role for genetic factors in autism, [3] [4] [5] with a complex mode of inheritance. Statistical models suggest that between 2 and 10 loci are probably implicated 6 (for a review see Lamb et al 7 ) . The first genome screen reported a multipoint maximum LOD score (MLS) of 2.53 on the long arm of human chromosome 7 (AUTS1). 8 Further analysis of the AUTS1 locus has been presented by IMGSAC, 9 with a multipoint MLS of 3.37 on chromosome 7q22. Several independent genome screens support the presence of an autism locus on chromosome 7q; also cytogenetic studies strengthen the role of chromosome 7q in autism (reviewed in Lamb et al 7 ). The human reelin gene maps to chromosome 7q22, close to the peak of linkage reported by IMGSAC. Reelin protein plays an important role in neuronal migration during brain development. 10 Reeler mice, natural null mutants, carry large deletions of the reelin gene and show pronounced neurological symptoms (eg dystonia, ataxia and tremors) and neuroanatomical abnormalities in the positioning of neurons throughout the cerebral cortex, cerebellum and hippocampus. 11 The male heterozygous mouse (rln/À) does not show the same phenotypic abnormalities, but a postnatal decrease in the number of Purkinje cells. 12 Mutations in the human gene have been identified in two cases of autosomal recessive lissencephaly. 13 Several lines of evidence suggest a role for reelin in autism: the gene maps to one of the regions of interest and there is significant overlap between the areas of developmental alterations in reeler mice and regions where abnormalities in autistic brains have been found, for example, the cerebral cortex, brainstem and cerebellum.
14, 15 Persico et al 16 reported preferential transmission of long alleles of a triplet repeat at the 5 0 UTR in autism. However, further independent studies reported conflicting findings (reviewed in Fatemi 17 ). We report here the molecular screening of the gene and an association study of the triplet repeat and intragenic polymorphisms to identify possible variants leading to autism susceptibility.
Results
In total, 55 independent autistic patients (49 males, six females) were selected from those IMGSAC multiplex families showing increased marker allele sharing identical by descent (IBD) at the peak of linkage on chromosome 7q22, 9 to enrich for individuals likely to carry aetiological variants. The promoter region was defined using the program PromoterInspector. The exon-intron organisation was obtained by BLAST search using the human cDNA sequence (GenBank Accession no. U79716); alignment of the mRNA with the genomic sequence demonstrates that the gene covers a genomic region of at least 340 kb. Ten missense variants were identified in the 55 autistic individuals. Exons harbouring these variants were subsequently tested in all the remaining affected individuals of the IMGSAC collection (342 individuals, 281 males, 61 females) from 169 families. In addition, 192 random Caucasian controls (96 males, 96 females) from the European Centre for Collection of Animal Cell Cultures (ECACC) were tested for the presence of these variants. Results are reported in Table 1 . Five missense variants were not identified in the control group, in exons 10, 25, 35, 44 and 51. The G1283C transversion in exon 10 (G370R), identified in one family, is transmitted maternally to one of the three male affected children. The C3652A transversion in exon 25 (N1159K), identified in one family, is transmitted maternally to both the affected sisters (no DNA was available for the unaffected brother). The G5459A transition in exon 35 (V1762I), found in two families, is transmitted maternally to the affected sibs in a female-female and male-male sib pair. Interestingly, the family with a female-female sib pair also carries the N1159K substitution. The variant G7044A in exon 44 (R2290H), identified in one family, is transmitted paternally to both the affected sibs (male-female sib pair). The A8327G transition in exon 51 (T2718A) is transmitted paternally to the two affected sibs (male-female pair) but not to the unaffected brother. When screening these exons in the larger IMGSAC sample, two new missense variants were identified: T1188G in exon 10 (V338G) and C5399T in exon 35 (R1742W). These variants were not detected in any controls but do not cosegregate with the autism phenotype in the IMGSAC sample. Exons 25, 35 , 44 and 51 were tested in an independent German collection of 158 autistic individuals (125 males, 33 females) from 134 singleton and 12 multiplex families and in 197 independent German controls (101 males, 96 females). The results are shown in Table 1 . None of these missense variants was found in the German controls. Three singleton families carried both the exon 25 C3652A (N1159K) and the exon 35 G5459A (V1762I) variants, transmitted paternally to the affected child (two males, one female). These results agree with our finding from the IMGSAC family, which carries both the N1159K and the V1762I substitutions. A new missense variant was identified in exon 35, G5400A (R1742Q) in one singleton family, transmitted paternally to the affected male child; this variant, affecting the same amino acid as the C5399T variant found in the IMGSAC families, was not identified in either the IMGSAC sample or control groups. In addition, a new missense variant was found in one German control, G7050A (R2292H).
Five missense variants, in exons 15, 22, 27, 34 and 47 (reported in Table 1 ), were identified in the ECACC controls with a similar frequency as in the autistic individuals. The A2063C transversion in exon 15 (S630R) and the C3164G transversion in exon 22 (L997V) are frequent polymorphisms. The G4014A transition in exon 27 (G1280E) was found in nine IMGSAC families and affects a residue important for the putative activity of Reelin as a serine protease. 18 However, the G4014A transition cosegregates with the autistic phenotype in only three families and was also detected in a father, who did not transmit it to the affected children. Variant C5331T in exon 34 (S1719L) was identified in two families, transmitted maternally in the first to the two affected sibs (male-male pair) and not to the unaffected sister, and transmitted paternally in the second family, to both the affected sibs (male-male pair), but not to the unaffected sister. The G7613A transition in exon 47 (G2480S) was found in four families, but it cosegregates with the Five single nucleotide polymorphisms (SNPs) were identified in the promoter region, not in any predicted regulatory element, and 15 intronic and 11 silent changes were found. Two SNPs, in intron 5 (2 bp before the 5 0 splice site) and in exon 50 (silent), were previously described. To investigate the possibility that variants with no apparent functional significance may play a role by subtly affecting gene expression, the polymorphic triplet repeat located at the 5 0 UTR and intragenic SNPs were genotyped in 169 IMGSAC families and tested for association with autism using the transmission disequilibrium test (TDT). 19 The triplet repeat was also tested in 122 German singleton families. No evidence for association with this polymorphism was found in any of the analysed groups (P40.05) ( Table 2 ). The subdivision in the German sample according to development of language also did not show any significant result. The SNPs in intron 5, exon 22 and exon 50 showed no evidence for association within the IMGSAC sample ( Table 3 ). The SNP in intron 31 showed a trend towards transmission disequilibrium of maternal alleles (61 transmissions vs 38 nontransmissions for allele 2; P ¼ 0.023); however, given the number of tests performed, this positive result may have arisen by chance. The distribution of linkage disequilibrium was studied using the standardised disequilibrium measure D 0 , 20 calculated using the GOLD program. 21 Significant linkage disequilibrium was detected between the SNPs in exon 22 and intron 31 (D 0 ¼ 0.781). Following the identification of cosegregating novel missense mutations in the reelin gene, we attempted to identify shared phenotypic features in the IMGSAC novel mutation group and in the German sample of autistic individuals in whom novel mutations had been found (German novel mutation group). Autism diagnostic interview (ADI) 22 data on these groups were compared with data from cases that had originally been screened for mutations, and in which none had been found. As a result of the presence of neurological symptoms and abnormalities in brain structure at a microscopic and macroscopic level in mouse models, the relative frequencies of macrocephaly and gross and fine motor dyspraxia in these groups were also examined.
All eight cases in the IMGSAC novel mutation group had language delay and autism, but only three had meaningful language; there was an equal sex ratio, contrasting with the male to female ratio of 7 : 1 in the comparison group. Even the three cases who did have useful language were more affected than those with meaningful language in the comparison group, having higher mean verbal communication ADI domain scores suggesting significant language impairment in all eight cases. The remainder of the ADI domain scores was similar to the comparison group. In addition, IMGSAC novel mutation cases had lower performance IQ and social and daily living Vineland domain scores (not significant) than the comparison group, although the communication domain scores were similar.
The German novel mutation group contained three males and one female; all cases had language delay, no useful language and a diagnosis of autism. All cases in the German novel mutation group were severely affected; none of these cases had sufficiently advanced language to score on the verbal domain of the ADI, and in 3/4 cases performance IQ was untestable. Vineland communication scores for this group were lower than the comparison group. Overall, the phenotypic findings in the German cases in which novel mutations were found were consistent with the findings in the IMGSAC novel mutation group. These results, and those of the comparison group are shown in Table 4 .
We could find no evidence of a common behavioural phenotype that differentiated novel mutation cases from the remainder of the study cases. Further phenotypic analysis was unable to identify a group of individuals who were similar enough to cases with cosegregating mutations and dissimilar enough to the remainder of the included cases to identify 'phenotypic candidate families' for mutation screening.
In order to assess the aetiological significance of these results, a number of factors need to be considered. Little is known about the nature of genetic variation underlying complex disease in humans. One problem is to identify whether genetic variance is because of a small number of loci at which susceptibility alleles are commonFthe 'common disease, common variant' hypothesisFor because of a much larger number of loci at which susceptibility alleles are quite rare. 23 However, in samples enriched for disease-related alleles, even if the frequency of any single variant is low, the combined frequency of these high-risk variants is expected to be significantly different from that in control samples. Linkage and cytogenetic studies have implicated several regions of interest in the aetiology of autism, the long arm of chromosome 7 being one of the most significant. We report the results of the systematic screening of the human reelin gene, localised on chromosome 7q22. A total of 10 missense variants were found in the original panel of 55 autistic patients and two additional missense variants were subsequently identified in the larger IMGSAC sample. Seven variants were not identified in the control group, although three of them do not cosegregate in all the affected individuals and may be considered private polymorphisms. The four remaining variants were found only in the IMGSAC families, in both the affected siblings. When screening these four exons in an independent German sample a new missense variant was found, and three families were identified harbouring both the N1159K and V1762I changes, as seen in the IMGSAC sample. The phenotypic characteristics of the IMGSAC and German autistic cases with novel mutations differed In general, coding SNPs that change the amino-acid sequence and most likely influence function are found at a lower rate and with lower frequency than silent substitutions. In addition, there is a high degree of homology in reelin from different species, suggesting a selective pressure against mutations. All the variants identified in the coding sequence reside in highly conserved positions and many are nonconservative changes that may potentially alter its then regulation and function.
In the heterozygous mice (rln/ þ ) Reelin levels are reduced and Purkinje cells in the cerebellum degenerate because of the lack of trophic effects of Reelin. 24 Interestingly, a reduction of Reelin protein in the cerebellar extract of autistic individuals was reported by Fatemi et al 25 The majority of variants in this study were identified in heterozygous individuals, suggesting that if they have an impact on the protein function this may be similar to the heterozygous mouse phenotype.
The identification of novel missense mutations is interesting; however, the low frequency of these mutations does not explain the relatively strong linkage results on chromosome 7q. Support for reelin as an autism susceptibility gene would be enhanced by studies in other independent autism samples and analysis of phenotypic characteristics by other groups is necessary to clarify the significance of variants. In this study, two of the variants identified in the IMGSAC sample and a new missense variant were found in the independent German sample, indicating the importance of further studies. Although reelin does not seem to play a major role in autism susceptibility, the variants identified may be important in a small subgroup of autistic individuals, 
Material and methods

IMGSAC families and German sample of autistic individuals
The identification of families and assessment methods used by the IMGSAC have been previously described. 9 Briefly, in families passing an initial screen, parents were administered the ADI-R 22 and the Vineland Adaptive Behaviour Scales. 26 Potential cases were assessed using the ADOS. 27 Physical examination was undertaken to exclude recognisable medical causes, particularly tuberous sclerosis. Karyotyping was performed when possible on all affected individuals and molecular genetic testing for Fragile X performed on one case per family. Written informed consent was given by all parents/ guardians and, where possible, by affected individuals. The study has been reviewed by the relevant ethical committees.
Diagnostic criteria for the German family sample have been adapted according to consortium rules based on the previous description by Klauck et al.
28
The German sample of probands fulfilling all diagnostic criteria was further subdivided in groups A and B, with probands from group B showing no delay in the development of language.
Mutation screening of the reelin gene PCR amplifications were performed in a final volume of 50 ml containing 40 ng of genomic DNA extracted from blood, 1.5-2.5 mM MgCl 2 , 0.2 mM dNTPs, 0.2 mM each primer and a mixture of 0.9 U Taq Gold Polymerase (Applied Biosystems) and 0.05 U PFU Turbo DNA Polymerase (Stratagene) in a standard KCl buffer. For GC-rich regions, PCR amplifications were performed with the addition of 5% DMSO and 100 mM 7-deaza-2 0 -deoxyguanosine-5 0 -triphosphate (Amersham Pharmacia Biotech Inc.). In total, 40 cycles were performed with a touch-down protocol (14 cycles of 30 s at 951C, 30 s at T1-0.51C/cycle, 30 s at 721C, followed by 26 cycles of 30 s at 951C, 30 s at T2, 30 s at 72 o C). Primers for the promoter region, exon-intron boundaries and 3 0 UTR were designed using the program Primer 3. Primer sequences and PCR conditions are available from the authors on request. PCR products were purified using the Multiscreen s -PCR plates (Millipore) by vacuum filtration, resuspended in H 2 O mQ and sequenced on both strands with the BigDye kit (Applied Biosystems) according to the manufacturer's instructions. Sequences were loaded on ABI377 semiautomated machines and analysed using the Sequence Navigator version 3.1 program. For the promoter analysis, PCR products from genomic DNA were subjected to denaturing high-performance liquid chromatography (DHPLC) analysis using the WAVE TM DNA Fragment Analysis System (Transgenomic) as described. 29 Samples showing a variant DHPLC pattern were sequenced to determine the nature of the heterozygous change.
DHPLC screening in German sample
Screening of exons 25, 35, 44 and 51 was carried out using DHPLC as described; 29 and the conditions optimised for the position of the four variants in the corresponding exons. Fragments showing a variant pattern were subsequently reamplified and sequenced as described before.
Genotyping of SNPs and microsatellites
Fluorescently labelled primers were designed and used to amplify the RELN triplet repeat. Products were genotyped on ABI377 sequencing machines (PE Applied Biosystems), as described previously. 9 The two SNPs in intron 5 and exon 50 were genotyped by restriction digestion using the enzymes PvuII and NlaIII, respectively. PCR products were digested in a 10 ml reaction volume with the appropriate enzyme (New England Biolabs), according to the manufacturer's instructions. Fragments were separated on a 2.5% agarose gel for PvuII digests, and on a 4% 3 : 1 NuSieve GTG agarose (FMCBioproducts): standard agarose gel for NlaIII digests.
Primer extension using the MassARRAY t for exon 22 and intron 31 SNPs Genotyping assays were designed using Sequenom's SpectroDESIGNERt software (Version 1.3.4) and genotypes obtained using the MassARRAYt system. This procedure is based on an allele-specific primer extension reaction differentiating genotypes. PCR amplifications were performed in a 384-well plate in a final volume of 10 ml containing 24 ng of genomic DNA extracted from blood, 2-2.5 mM MgCl 2 , 0.2 mM dNTPs, 0.05 mM each primer and 0.1 U HotStarTaq (Qiagen) for 45 cycles (20 s at 941C, 30 s at 52-541C, 1 min at 72 o C). Unincorporated PCR constituents were removed using shrimp alkaline phosphatase (SAP) at 371C for 20 min followed by 851C for 5 min. The primer extension reactions were cycled 55 times (5 s at 941C, 5 s at 521C, 5 s at 721C). Excess dNTPs/ ddNTPs were removed using SpectroCLEANt resin. Samples were spotted onto 384-well SpectroCHIPst. The chip was read using the Bruker Biflex III Mass Spectrometer system and genotypes were allocated using SpectroTYPERt software.
Association and linkage disequilibrium analysis TDT 19 was performed using the sib_tdt program from the ASPEX package. This program calculates probabilities for 2 statistics by permuting parental alleles while fixing the IBD status of siblings within a family, thereby allowing the use of multiple siblings within a nuclear family; this is a valid test for association in the presence of linkage. For the German singleton sample, consisting of 122 families, a maximum TDT statistic for the individual alleles was used to test for marker allele association. A randomization procedure was applied and an empirical P-value was computed based on the 10 000 permutations used in the procedure. 30 The extent of linkage disequilibrium between the 5 0 triplet repeat and the intragenic SNPs was studied using Lewontin's standardised measure of disequilibrium D 0 , and calculated using the GOLD program.
Notes: The data for the noncoding and silent SNPs are available on the Website online.
